The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics

E Pajarillo, A Rizor, J Lee, M Aschner, E Lee - Neuropharmacology, 2019 - Elsevier
Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS)
which initiates rapid signal transmission in the synapse before its re-uptake into the …

A selective review of the excitatory-inhibitory imbalance in schizophrenia: underlying biology, genetics, microcircuits, and symptoms

Y Liu, P Ouyang, Y Zheng, L Mi, J Zhao… - Frontiers in cell and …, 2021 - frontiersin.org
Schizophrenia is a chronic disorder characterized by specific positive and negative primary
symptoms, social behavior disturbances and cognitive deficits (eg, impairment in working …

Excitatory amino acid transporters in physiology and disorders of the central nervous system

AR Malik, TE Willnow - International journal of molecular sciences, 2019 - mdpi.com
Excitatory amino acid transporters (EAATs) encompass a class of five transporters with
distinct expression in neurons and glia of the central nervous system (CNS). EAATs are …

The role of SLC transporters for brain health and disease

YTK Nguyen, HTT Ha, TH Nguyen… - Cellular and Molecular Life …, 2022 - Springer
The brain exchanges nutrients and small molecules with blood via the blood–brain barrier
(BBB). Approximately 20% energy intake for the body is consumed by the brain. Glucose is …

Role of oxidative stress in hepatic and extrahepatic dysfunctions during nonalcoholic fatty liver disease (NAFLD)

A Gonzalez, C Huerta-Salgado… - Oxidative Medicine …, 2020 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is a pathology that contains a broad liver
dysfunctions spectrum. These alterations span from noninflammatory isolated steatosis until …

Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders

P Chakraborty, A Dey, AV Gopalakrishnan… - Ageing Research …, 2023 - Elsevier
In the mammalian brain, glutamate is regarded to be the primary excitatory neurotransmitter
due to its widespread distribution and wide range of metabolic functions. Glutamate plays …

A medicinal chemistry perspective on excitatory amino acid transporter 2 dysfunction in neurodegenerative diseases

IC Fontana, DG Souza, DO Souza, A Gee… - Journal of medicinal …, 2023 - ACS Publications
The excitatory amino acid transporter 2 (EAAT2) plays a key role in the clearance and
recycling of glutamate-the major excitatory neurotransmitter in the mammalian brain. EAAT2 …

[HTML][HTML] Protein glycosylation and glycoinformatics for novel biomarker discovery in neurodegenerative diseases

J Costa, C Hayes, F Lisacek - Ageing research reviews, 2023 - Elsevier
Glycosylation is a common post-translational modification of brain proteins including cell
surface adhesion molecules, synaptic proteins, receptors and channels, as well as …

Glutamate transport and preterm brain injury

S Pregnolato, E Chakkarapani, AR Isles… - Frontiers in …, 2019 - frontiersin.org
Preterm birth complications are the leading cause of child death worldwide and a top global
health priority. Among the survivors, the risk of life-long disabilities is high, including cerebral …

Neuroprotective effect of menaquinone-4 (MK-4) on transient global cerebral ischemia/reperfusion injury in rat

B Farhadi Moghadam, M Fereidoni - Plos one, 2020 - journals.plos.org
Cerebral ischemia/reperfusion (I/R) injury causes cognitive deficits, excitotoxicity,
neuroinflammation, oxidative stress and brain edema. Vitamin K2 (Menaquinone 4, MK-4) …